Atherosclerosis
Sort by:
Cleveland Clinic Heart, Vascular and Thoracic Institute
Who Should Get a CAC? How Often? How to Use the Results to Assess Risk?
FEATURING
Milind Desai
- 5 views
- December 18, 2024
Cleveland Clinic Heart, Vascular and Thoracic Institute
Targeting Lp(a)
FEATURING
Leslie Cho
- 6 views
- December 18, 2024
MonteHeart Imaging & Clinical Lectures
AI and Tech for CVD Prevention: Hope, Hype, and Dr. ChatGPT
FEATURING
Ashish Sarraju
- 7 views
- December 9, 2024
Norman Lepor
The Role of Inflammation and Its Management in Cardiometabolic Disease
- 777 views
- December 5, 2024
- 10
Right Care Initiative
Fight Heart Disease Like Cancer: Shifting the Paradigm and Empowering Patients
FEATURING
Michael Mcconnell
- 9 views
- December 2, 2024
AHA 2024 Insights
AHA 2024 Insights: Phase 2 Trial of Zerlasiran: Multiple Doses of an siRNA Targeting Lipoprotein(a) Over 60 Weeks
FEATURING
Steven Nissen
- 1,135 views
- November 19, 2024
- 8
The American Society for Preventive Cardiology
CAC Is the Imaging Modality of Choice in Refining ASCVD Risk in Primary Prevention
FEATURING
Seamus Whelton
- 86 views
- November 15, 2024
- 1
The American Society for Preventive Cardiology
CCTA Is the Imaging Modality of Choice in Refining ASCVD Risk in Primary Prevention
FEATURING
Matthew Budoff
- 89 views
- November 15, 2024
Right Care Initiative
Intravascular Plaque Anatomic Changes with Lipid Lowering Therapy - Why Optimal Medication Management Matters
FEATURING
Matthew Budoff
- 617 views
- November 15, 2024
- 5
Amir Ahmadi
CT Guided Treatment of Coronary Artery Disease: A Step Towards Precision Medicine
- 910 views
- October 17, 2024
- 8
Matthew Budoff
Management of Atherosclerotic Cardiovascular Disease: V-Initiate Study
- 2,103 views
- September 27, 2024
- 10
European Menopause and Andropause Society
Effects of Menopause Hormone Treatment on Atherosclerosis Progression
FEATURING
Eleni Armeni
- 380 views
- September 24, 2024
- 8
Novartis Cardiology
Understanding Acquisition and Billing for a Non-Statin Lipid-Lowering Therapy
FEATURING
Bobbi Buell
- 1,343 views
- August 30, 2024
- 6
Novartis Cardiology
Initiating and Monitoring Patients on a Non-Statin Lipid-Lowering Therapy: Provider Experiences
- 1,476 views
- August 30, 2024
- 2
Novartis Cardiology
Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowering Therapy
- 1,396 views
- August 30, 2024
- 4
Novartis Cardiology
Expert Insights on Adding a Non-Statin Lipid-Lowering Therapy in a Real-World Setting
FEATURING
Michael Koren
- 1,504 views
- August 30, 2024
- 9
Novartis Cardiology
Expert Insights on Pivotal Phase 3 and Long-term Trial Data in Primary Hyperlipidemia
FEATURING
Dean G. Karalis,
Merle Myerson
- 1,160 views
- August 30, 2024
- 3
Cleveland Clinic Neurological Institute
Vascular Health and the Aging Brain
FEATURING
Ashfaq Shuaib
- 131 views
- August 21, 2024
Canadian Collaborative Research Network
VICTORION-INITIATE – Comparing Inclisiran First to Usual Care in Patients with ASCVD
FEATURING
Milan Gupta
- 159 views
- August 20, 2024
- 4
Canadian Collaborative Research Network
VICTORION-INITIATE Trial – a Post-Lecture Discussion
FEATURING
Narendra Singh,
Milan Gupta
- 5 views
- August 20, 2024
Georgia Heart Institute
Imaging to Improve Screening and Diagnosis of CVD in Women – a Post-Lecture Interview
FEATURING
Jaime Burkle,
Gina Lundberg
- 82 views
- August 14, 2024
- 1
Georgia Heart Institute
Risk Factor Modification for Inflammation – a Post-Lecture Interview
FEATURING
Angela Taylor,
Arshed Quyyumi
- 9 views
- August 14, 2024